US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...
Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...
Stamford, Connecticut-based SpringWorks' Gomekli (mirdametinib) has become the first medicine approved for both adults and ...
Martin, who was appointed as Inspector General for the USAID towards the end of 2023 by former President Joe Biden, was ...
At JP Morgan last month, pharmaphorum editor-in-chief Jonah Comstock caught up with Paul Hastings, the CEO of Nkarta, to talk ...
The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...
Recognising that challenge, AstraZeneca's rare disease unit Alexion has launched an interactive storybook that can help ...
Super Bowl ads aren’t just entertainment; they’re cultural barometers. They reflect what resonates with audiences, what ...
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...
Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 ...
At JPM Week 2025 in San Francisco, pharmaphorum editor-in-chief Jonah Comstock met with Rick Stewart, CEO of Achieve Life ...
This can help individuals feel fuller for longer and can promote weight loss. When measured by traditional weight loss ...